The FDA has approved a groundbreaking clinical trial that will test the safety of transplanting genetically modified pig kidneys into individuals with chronic kidney disease. This development aims to address the critical shortage of donor organs for patients who can no longer rely on their own kidneys. While previous surgeries using pig organs on a compassionate basis have seen limited success, the new formal trials will adhere to standardized procedures to gather vital safety and efficacy data, which could transform the future of organ transplantation and save lives.
The first clinical trial testing whether pig kidneys can be safely transplanted into living people has been approved by the US Food and Drug Administration (FDA).
The formal clinical trials are standardized, which allows the collection of crucial safety and efficacy data to move the field forward.
Collection
[
|
...
]